Prudential Financial Inc Tg Therapeutics, Inc. Transaction History

Prudential Financial Inc

$74.4 Billion
Q2 2025

A detailed history of Prudential Financial Inc transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 189,315 shares of TGTX stock, worth $5.74 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

189,315

Previous 179,390 5.53%

Holding current value

$5.74 Million

Previous $7.07 Million 3.68%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$33.37 - $45.51 $331,197 - $451,686	9,925 Added 5.53%	189,315 $6.81 Million
Q1 2025 May 13, 2025	BUY	$27.67 - $42.99 $299,251 - $464,936	10,815 Added 6.42%	179,390 $7.07 Million
Q4 2024 Feb 11, 2025	SELL	$21.31 - $35.09 $2.91 Million - $4.8 Million	-136,762 Reduced 44.79%	168,575 $5.07 Million
Q3 2024 Nov 13, 2024	BUY	$17.21 - $25.28 $3.78 Million - $5.56 Million	219,748 Added 256.75%	305,337 $7.14 Million
Q2 2024 Aug 13, 2024	BUY	$13.32 - $19.19 $999,466 - $1.44 Million	75,035 Added 710.96%	85,589 $1.52 Million
Q1 2024 May 14, 2024	SELL	$13.02 - $21.3 $13 - $21	-1 Reduced 0.01%	10,554 $160,000
Q4 2023 Feb 13, 2024	BUY	$6.68 - $18.81 $2,204 - $6,207	330 Added 3.23%	10,555 $180,000
Q3 2023 Nov 13, 2023	SELL	$8.36 - $26.5 $376,467 - $1.19 Million	-45,032 Reduced 81.5%	10,225 $85,000
Q2 2023 Aug 11, 2023	SELL	$15.48 - $35.0 $1.37 Million - $3.09 Million	-88,338 Reduced 61.52%	55,257 $1.37 Million
Q1 2023 May 12, 2023	BUY	$10.23 - $19.34 $1.47 Million - $2.78 Million	143,595 New	143,595 $2.16 Million
Q1 2022 May 13, 2022	SELL	$7.81 - $20.45 $73,343 - $192,045	-9,391 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$15.2 - $35.51 $16,735 - $39,096	-1,101 Reduced 10.49%	9,391 $327,000
Q3 2021 Nov 15, 2021	SELL	$21.78 - $40.45 $15,093 - $28,031	-693 Reduced 6.2%	10,492 $328,000
Q2 2021 Aug 16, 2021	BUY	$32.5 - $48.96 $10,075 - $15,177	310 Added 2.85%	11,185 $434,000
Q1 2021 May 12, 2021	BUY	$41.61 - $54.3 $23,551 - $30,733	566 Added 5.49%	10,875 $524,000
Q4 2020 Feb 16, 2021	BUY	$25.27 - $54.9 $16,703 - $36,288	661 Added 6.85%	10,309 $536,000
Q3 2020 Aug 05, 2021	BUY	$18.49 - $27.24 $178,391 - $262,811	9,648 New	9,648 $259,000

Others Institutions Holding TGTX

# of Institutions

400

Shares Held

90.7M

Call Options Held

2.28M

Put Options Held

1.68M

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.4B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Account

Prudential Financial Inc Tg Therapeutics, Inc. Transaction History